What is Healthcare Svcs Group Inc's earnings per share (EPS)?

Healthcare Svcs Group Inc (HCSG) reported diluted earnings per share of $0.81 for fiscal year 2025. This represents a 52.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Svcs Group Inc (HCSG) Financials

HCSG

Trailing 12 months to June 30, 2026

Revenue $1.9B +5.2% YoY

Net Income $123.0M +1037.2% YoY

EPS (Diluted) $1.71 +1121.4% YoY

Free Cash Flow $148.5M +63.4% YoY

Market Cap $1.5B as of Sep 10, 2026

Price / Sales 0.8x on $1.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 12.3x on $123.0M net income, trailing 12 months to June 30, 2026

Price / Book 2.9x on $518.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 24, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HCSG SEC filings page.

Healthcare Svcs Group Inc (HCSG) reported $1.9B in revenue over the twelve months to Jun 30, 2026, up 5.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCSG FY2025 2026-09-05

Cash conversion became the dominant mechanic as earnings improved, while leverage eased and shareholder distributions accelerated.

In FY2025, operating cash flow of $145M was more than twice net income of $59.1M. Free cash flow of $139M nearly matched that cash flow, showing the earnings improvement arrived with unusually strong cash conversion rather than merely accounting profit.

The margin shape is notable: gross margin edged down from 13.3% in FY2024 to 13.0% in FY2025, so the profit improvement was not driven by broader gross economics. Net margin rose to 3.2% as interest expense fell to $1.6M, suggesting below-gross-profit items helped the bottom line.

Liabilities fell from $303M in FY2024 to $284M in FY2025, reducing the claims ahead of equity. Shares outstanding fell from 73.5M to 70.3M, indicating that part of the stronger cash generation was returned through repurchases.

Financial Health Signals

Financial Health Score 39/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Healthcare Svcs Group Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Healthcare Svcs Group Inc, and counted as zero in the overall score.

Growth

Healthcare Svcs Group Inc's revenue grew 7.1% year-over-year to $1.8B, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

Healthcare Svcs Group Inc has a moderate D/E ratio of 0.56. This balance of debt and equity financing earns a leverage score of 59/100.

Liquidity

With a current ratio of 3.38, Healthcare Svcs Group Inc holds $3.38 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 83/100.

Cash Flow

Healthcare Svcs Group Inc has a free cash flow margin of 7.6%, earning a moderate score of 44/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Healthcare Svcs Group Inc, and counted as zero in the overall score.

Piotroski F-Score Partial

7/8

Healthcare Svcs Group Inc passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.45x

For every $1 of reported earnings, Healthcare Svcs Group Inc generates $2.45 in operating cash flow ($145.0M OCF vs $59.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$470.8M

YoY+2.7%

QoQ+1.7%

5Y CAGR+3.4%

10Y CAGR+2.0%

Healthcare Svcs Group Inc generated $470.8M in revenue in Q2 2026. This represents an increase of 2.7% from the same quarter a year earlier. Against the prior quarter it is up 1.7%.

Net Income

$22.7M

YoY+170.1%

QoQ-12.9%

5Y CAGR+18.9%

10Y CAGR+1.9%

Healthcare Svcs Group Inc reported $22.7M in net income in Q2 2026. This represents an increase of 170.1% from the same quarter a year earlier. Against the prior quarter it is down 12.9%.

EPS (Diluted)

$0.32

YoY+172.7%

QoQ-13.5%

5Y CAGR+19.7%

10Y CAGR+2.1%

Healthcare Svcs Group Inc earned $0.32 per diluted share (EPS) in Q2 2026. This represents an increase of 172.7% from the same quarter a year earlier. Against the prior quarter it is down 13.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$20.2M

YoY-26.2%

QoQ-52.2%

5Y CAGR-3.4%

10Y CAGR+8.4%

Healthcare Svcs Group Inc generated $20.2M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 26.2% from the same quarter a year earlier. Against the prior quarter it is down 52.2%.

Cash & Debt

$123.4M

YoY+49.0%

QoQ-9.4%

5Y CAGR-0.2%

10Y CAGR+19.0%

Healthcare Svcs Group Inc held $123.4M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

69M

YoY-5.2%

QoQ0.0%

5Y CAGR-1.7%

10Y CAGR-0.5%

Healthcare Svcs Group Inc had 69M shares outstanding in Q2 2026. This represents a decrease of 5.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

15.9%

YoY+15.2pp

QoQ-0.5pp

5Y CAGR+0.4pp

Healthcare Svcs Group Inc's gross margin was 15.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 15.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Net Margin

4.8%

YoY+11.9pp

QoQ-0.8pp

5Y CAGR+2.4pp

10Y CAGR0.0pp

Healthcare Svcs Group Inc's net profit margin was 4.8% in Q2 2026, showing the share of revenue converted to profit. This is up 11.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Return on Equity

4.4%

YoY+11.2pp

QoQ-0.7pp

5Y CAGR+2.4pp

10Y CAGR-1.4pp

Healthcare Svcs Group Inc's ROE was 4.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 11.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$20.9M

YoY+172.7%

QoQ-12.7%

Healthcare Svcs Group Inc spent $20.9M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 172.7% from the same quarter a year earlier. Against the prior quarter it is down 12.7%.

Capital Expenditures

$1.6M

YoY+19.9%

QoQ+16.6%

5Y CAGR+5.6%

10Y CAGR+0.9%

Healthcare Svcs Group Inc invested $1.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 19.9% from the same quarter a year earlier. Against the prior quarter it is up 16.6%.

R&D Spending

Not reported for Q2 2026.

HCSG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCSG quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.9B	$1.8B+7.1%	$1.7B+2.7%	$1.7B-1.1%	$1.7B+2.9%	$1.6B-6.7%	$1.8B-4.4%	$1.8B-8.1%	$2.0B+7.6%	$1.9B+19.1%	$1.6B+8.8%	$1.4B+11.1%	$1.3B+12.5%	$1.1B+6.7%	$1.1B+21.2%	$889.1M
Cost of Revenue	$1.5B	$1.6B+7.4%	$1.5B+2.1%	$1.5B-2.7%	$1.5B+6.1%	$1.4B-5.4%	$1.5B-7.5%	$1.6B-8.8%	$1.8B+9.8%	$1.6B+20.2%	$1.3B	N/A	N/A	N/A	N/A	N/A
Gross Profit	$319.1M	$239.4M+5.0%	$228.1M+6.2%	$214.7M+11.1%	$193.3M-16.2%	$230.6M-14.0%	$268.0M+17.6%	$227.9M-2.8%	$234.4M-6.5%	$250.6M+12.3%	$223.2M	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$191.3M	$190.9M+4.3%	$183.1M+9.8%	$166.8M+18.8%	$140.3M-18.9%	$173.1M+14.8%	$150.8M+0.5%	$150.0M+9.8%	$136.6M+7.8%	$126.7M+20.2%	$105.4M-5.6%	$111.7M+3.6%	$107.8M+17.2%	$92.0M+16.0%	$79.3M+21.4%	$65.3M
Interest Expense	$1.8M	$1.6M-75.5%	$6.4M-18.0%	$7.9M+163.0%	$3.0M+115.7%	$1.4M+0.8%	$1.4M-60.3%	$3.5M+11.8%	$3.1M+127.0%	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$28.5M	$8.8M-34.6%	$13.5M-8.2%	$14.7M+42.3%	$10.3M-39.2%	$17.0M-44.4%	$30.5M+48.7%	$20.5M+25.2%	$16.4M-63.4%	$44.7M+4.1%	$43.0M+35.4%	$31.7M+222.0%	$9.9M-49.1%	$19.4M-25.7%	$26.1M+32.5%	$19.7M
Net Income	$123.0M	$59.1M+49.6%	$39.5M+2.8%	$38.4M+12.1%	$34.2M-29.5%	$48.5M-50.8%	$98.7M+52.8%	$64.6M-22.7%	$83.5M-5.3%	$88.2M+14.0%	$77.4M+33.4%	$58.0M+165.6%	$21.9M-53.6%	$47.1M+6.6%	$44.2M+15.9%	$38.2M
EPS (Basic)	N/A	$0.82+51.9%	$0.54+3.8%	$0.52+13.0%	$0.46-29.2%	$0.65-50.8%	$1.32+51.7%	$0.87-23.0%	$1.13-5.8%	$1.20+13.2%	$1.06+30.9%	$0.81+161.3%	$0.31-54.4%	$0.68+4.6%	$0.65+14.0%	$0.57
EPS (Diluted)	$1.71	$0.81+52.8%	$0.53+1.9%	$0.52+13.0%	$0.46-29.2%	$0.65-50.8%	$1.32+51.7%	$0.87-22.3%	$1.12-5.9%	$1.19+13.3%	$1.05+31.3%	$0.80+158.1%	$0.31-53.7%	$0.67+3.1%	$0.65+16.1%	$0.56
Diluted Shares (Avg)	N/A	73M-1.3%	74M-0.5%	74M0.0%	74M-0.8%	75M+0.2%	75M+0.3%	75M0.0%	75M+0.4%	74M+1.2%	73M+1.3%	73M+1.6%	71M+1.9%	70M+2.3%	68M+1.3%	68M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$470.8M+2.7%	$462.8M+3.4%	$466.7M+6.6%	$464.3M+8.5%	$458.5M+7.6%	$447.7M+5.7%	$437.8M+3.3%	$428.1M+4.1%
Cost of Revenue	$396.0M-13.1%	$386.9M+1.9%	$394.6M+4.1%	$367.9M+0.9%	$455.5M+18.4%	$379.7M+5.8%	$379.2M+8.6%	$364.7M-3.2%
Gross Profit	$74.8M+2428.5%	$75.8M+11.6%	$72.1M+23.0%	$96.4M+52.0%	$3.0M-92.9%	$68.0M+5.3%	$58.6M-21.6%	$63.4M+84.1%
SG&A Expenses	$52.6M+7.0%	$42.0M-6.6%	$46.2M+3.1%	$50.5M+7.8%	$49.2M+10.6%	$45.0M-4.1%	$44.8M-3.1%	$46.9M+20.1%
Interest Expense	$619K+48.1%	$365K-7.6%	$374K-68.3%	$393K-74.6%	$418K-75.6%	$395K-80.2%	$1.2M-42.8%	$1.5M-27.4%
Income Tax	$8.3M+187.2%	$8.5M+27.2%	-$2.7M-193.3%	$14.4M+200.4%	-$9.5M-4709.1%	$6.7M+11.0%	$2.9M-67.2%	$4.8M+471.5%
Net Income	$22.7M+170.1%	$26.1M+51.3%	$31.2M+162.1%	$43.0M+206.2%	-$32.4M-1710.2%	$17.2M+12.5%	$11.9M-49.3%	$14.0M+378.0%
EPS (Basic)	$0.33+175.0%	$0.37+60.9%	$0.44+158.8%	$0.59+210.5%	-$0.44-2100.0%	$0.23+9.5%	$0.17-45.2%	$0.19+371.4%
EPS (Diluted)	$0.32+172.7%	$0.37+60.9%	$0.43+168.8%	$0.59+210.5%	-$0.44-2100.0%	$0.23+9.5%	$0.16-48.4%	$0.19+371.4%
Diluted Shares (Avg)	70M-4.5%	71M-3.9%	N/A	73M-1.3%	73M-0.9%	74M-0.1%	N/A	74M-0.6%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

HCSG Balance Sheet

HCSG quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$794.3M-1.1%	$802.8M+1.5%	$790.7M+9.7%	$720.8M-7.6%	$779.9M-0.7%	$785.0M+8.6%	$722.6M+4.3%	$692.6M+2.5%	$676.0M+27.9%	$528.4M+9.9%	$480.9M+2.4%	$469.6M+10.4%	$425.3M+28.4%	$331.2M+14.3%	$289.7M
Current Assets	$576.4M+3.6%	$556.7M-2.6%	$571.7M+12.4%	$508.6M-6.9%	$546.4M-4.5%	$572.4M+11.0%	$515.7M+1.5%	$508.1M-3.7%	$527.4M+27.2%	$414.6M+13.5%	$365.3M+9.1%	$334.8M+8.3%	$309.2M+15.4%	$267.8M+15.4%	$232.1M
Cash & Equivalents	$125.2M+120.5%	$56.8M+4.5%	$54.3M+106.7%	$26.3M-62.9%	$70.8M-49.2%	$139.3M+409.8%	$27.3M+5.0%	$26.0M+172.3%	$9.6M-59.9%	$23.9M-28.1%	$33.2M-55.9%	$75.3M+17.3%	$64.2M-7.0%	$68.9M+78.4%	$38.6M
Short-Term Investments	$42.8M-15.4%	$50.5M-45.7%	$93.1M-2.2%	$95.2M-16.8%	$114.4M-8.5%	$125.0M+37.8%	$90.7M+18.8%	$76.4M+4.3%	$73.2M+8.1%	$67.7M-2.5%	$69.5M+489.0%	$11.8M+3.1%	$11.4M-46.3%	$21.3M-32.0%	$31.3M
Inventory	$16.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$281.3M-15.0%	$330.9M-4.0%	$344.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$79.8M+5.7%	$75.5M0.0%	$75.5M0.0%	$75.5M+1.0%	$74.8M+46.3%	$51.1M0.0%	$51.1M0.0%	$51.1M0.0%	$51.1M+15.0%	$44.4M0.0%	$44.4M0.0%	$44.4M+10.6%	$40.2M+137.0%	$17.0M0.0%	$17.0M
Total Liabilities	$284.0M-6.2%	$302.8M-9.3%	$334.0M+10.4%	$302.6M-9.6%	$334.7M+6.3%	$314.8M+20.0%	$262.3M+4.2%	$251.8M-8.8%	$276.1M+45.6%	$189.6M+2.8%	$184.5M-4.8%	$193.7M+38.2%	$140.2M+38.0%	$101.6M+41.2%	$72.0M
Current Liabilities	$170.4M-11.5%	$192.5M-11.2%	$216.9M+14.8%	$189.0M-1.1%	$191.1M+17.8%	$162.3M+9.2%	$148.7M-9.0%	$163.4M-11.3%	$184.2M+82.6%	$100.9M+5.0%	$96.1M-18.6%	$118.0M+19.0%	$99.1M+46.5%	$67.7M+49.1%	$45.4M
Non-Current Liabilities	$113.7M+3.1%	$110.3M-5.8%	$117.1M+3.1%	$113.5M-20.9%	$143.6M-5.8%	$152.5M+34.2%	$113.6M+28.5%	$88.4M-3.8%	$91.9M+3.5%	$88.7M+0.3%	$88.4M+16.7%	$75.8M+84.4%	$41.1M+21.1%	$33.9M+27.7%	$26.6M
Total Equity	$510.2M+2.1%	$499.9M+9.5%	$456.6M+9.2%	$418.3M-6.0%	$445.2M-5.3%	$470.3M+2.2%	$460.3M+4.4%	$440.8M+10.2%	$400.0M+18.0%	$338.8M+14.3%	$296.5M+7.5%	$275.8M-3.3%	$285.1M+24.2%	$229.6M+5.4%	$217.7M
Retained Earnings	$283.7M+26.3%	$224.6M+21.4%	$185.0M+26.2%	$146.6M-20.3%	$184.0M-8.4%	$200.9M+2.8%	$195.5M+2.8%	$190.1M+16.0%	$163.9M+25.1%	$130.9M+22.5%	$106.9M+6.6%	$100.2M-21.4%	$127.5M+0.3%	$127.0M+0.1%	$126.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$820.9M+2.3%	$814.8M-1.0%	$794.3M-1.1%	$804.3M-0.2%	$802.2M+0.3%	$823.0M+2.4%	$802.8M+1.5%	$805.8M+7.3%
Current Assets	$568.5M+6.8%	$601.2M+4.6%	$576.4M+3.6%	$580.6M+0.4%	$532.3M-7.1%	$575.0M-0.9%	$556.7M-2.6%	$578.1M+8.4%
Cash & Equivalents	$123.4M+49.0%	$136.2M+111.7%	$125.2M+120.5%	$124.4M+359.8%	$82.8M+213.3%	$64.3M+119.6%	$56.8M+4.5%	$27.1M-13.6%
Short-Term Investments	$41.3M-20.0%	$42.4M-15.9%	$42.8M-15.4%	$53.1M-30.9%	$51.7M-34.7%	$50.5M-33.2%	$50.5M-45.7%	$76.8M-14.7%
Inventory	$15.8M	N/A	$16.8M	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$292.8M+0.2%	$299.4M-11.4%	$281.3M-15.0%	$288.5M	$292.2M	$337.9M	$330.9M-4.0%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$85.8M+7.2%	$79.8M-0.3%	$79.8M+5.7%	$80.1M+6.0%	$80.0M+6.0%	$80.0M+6.0%	$75.5M0.0%	$75.5M0.0%
Total Liabilities	$302.0M-7.1%	$301.1M-2.5%	$284.0M-6.2%	$308.3M-2.8%	$325.2M-0.9%	$308.8M-6.2%	$302.8M-9.3%	$317.1M-0.2%
Current Liabilities	$188.1M-12.1%	$193.4M-2.7%	$170.4M-11.5%	$195.6M-0.8%	$213.9M+2.1%	$198.7M-5.1%	$192.5M-11.2%	$197.2M+5.0%
Non-Current Liabilities	$113.9M+2.4%	$107.7M-2.1%	$113.7M+3.1%	$112.7M-6.0%	$111.2M-6.4%	$110.0M-8.3%	$110.3M-5.8%	$119.9M-7.8%
Total Equity	$518.8M+8.8%	$513.8M-0.1%	$510.2M+2.1%	$496.0M+1.5%	$477.0M+1.2%	$514.2M+8.3%	$499.9M+9.5%	$488.7M+12.9%
Retained Earnings	$332.4M+58.7%	$309.7M+28.1%	$283.7M+26.3%	$252.4M+18.7%	$209.5M+5.5%	$241.8M+20.7%	$224.6M+21.4%	$212.6M+24.9%

Not reported in any period shown, so not listed: Long-Term Debt.

HCSG Cash Flow Statement

HCSG quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$154.3M	$145.0M+370.6%	$30.8M-29.2%	$43.5M+632.6%	-$8.2M-122.0%	$37.1M-82.9%	$217.2M+132.1%	$93.6M+16.9%	$80.0M+948.9%	$7.6M-81.6%	$41.4M-34.7%	$63.4M+9.8%	$57.7M+79.5%	$32.2M-46.7%	$60.4M+83.2%	$32.9M
Depreciation & Amortization	N/A	$16.8M+15.0%	$14.6M+1.7%	$14.3M-6.3%	$15.3M+4.4%	$14.7M+2.8%	$14.3M+2.4%	$13.9M+50.3%	$9.3M+4.3%	$8.9M+18.5%	$7.5M-2.1%	$7.7M+5.4%	$7.3M+17.2%	$6.2M+21.3%	$5.1M+16.6%	$4.4M
Stock-Based Compensation	N/A	$12.0M+31.0%	$9.2M+2.0%	$9.0M-2.5%	$9.2M+4.4%	$8.8M+12.1%	$7.9M+14.7%	$6.9M+16.4%	$5.9M-1.4%	$6.0M+40.8%	$4.3M+154.9%	$1.7M-45.8%	$3.1M+18.1%	$2.6M+2.7%	$2.5M+17.9%	$2.2M
Capital Expenditures	$5.7M	$5.8M-8.2%	$6.3M+17.2%	$5.4M+3.8%	$5.2M-8.4%	$5.7M+31.0%	$4.3M-0.6%	$4.4M-11.6%	$4.9M-8.5%	$5.4M-0.8%	$5.4M+8.9%	$5.0M-13.8%	$5.8M+54.0%	$3.8M+8.0%	$3.5M-37.2%	$5.5M
Free Cash Flow	$148.5M	$139.2M+468.7%	$24.5M-35.8%	$38.1M+384.8%	-$13.4M-142.6%	$31.4M-85.2%	$212.9M+138.6%	$89.2M+18.8%	$75.1M+3262.8%	$2.2M-93.8%	$36.0M-38.4%	$58.4M+12.4%	$51.9M+82.9%	$28.4M-50.1%	$56.9M+107.6%	$27.4M
Investing Cash Flow	-$19.5M	-$11.0M-282.0%	$6.0M+283.6%	-$3.3M-227.6%	$2.6M+111.2%	-$23.0M+37.6%	-$36.8M-123.9%	-$16.5M-71.7%	-$9.6M+36.0%	-$15.0M-132.0%	-$6.5M+89.6%	-$62.3M-864.6%	-$6.5M-1167.8%	$605K-89.4%	$5.7M+26.0%	$4.5M
Financing Cash Flow	-$94.5M	-$63.3M-104.0%	-$31.0M-155.5%	-$12.2M+68.8%	-$38.9M+52.9%	-$82.7M-20.9%	-$68.4M+9.8%	-$75.8M-40.5%	-$54.0M-675.6%	-$7.0M+84.3%	-$44.3M-2.7%	-$43.1M-7.5%	-$40.1M-6.9%	-$37.6M-5.0%	-$35.8M+7.2%	-$38.5M
Dividends Paid	N/A	N/A	$0	$0-100.0%	$63.4M+1.8%	$62.2M+2.5%	$60.7M+3.0%	$59.0M+3.1%	$57.2M+3.5%	$55.2M+3.6%	$53.3M+3.8%	$51.4M+4.7%	$49.1M+5.1%	$46.7M+5.9%	$44.1M+4.4%	$42.2M
Share Buybacks	$91.8M	$61.6M+1127.3%	$5.0M-55.5%	$11.3M	$0-100.0%	$21.5M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$21.9M-24.0%	$43.7M+59.0%	$17.4M-52.0%	$71.3M+1553.4%	$28.8M+76.4%	$27.5M+205.6%	$36.2M-26.8%	$4.3M+46.7%
Depreciation & Amortization	$3.5M-30.0%	$3.8M-1.9%	$3.9M+7.4%	$4.1M+7.9%	$5.0M+35.1%	$3.9M+9.8%	$3.6M-4.7%	$3.8M+18.8%
Stock-Based Compensation	N/A	$2.8M-26.1%	N/A	N/A	N/A	$3.7M+50.5%	N/A	N/A
Capital Expenditures	$1.6M+19.9%	$1.4M-19.8%	$1.4M-3.3%	$1.3M-4.5%	$1.4M+3.6%	$1.7M-20.7%	$1.4M-0.4%	$1.4M-25.4%
Free Cash Flow	$20.2M-26.2%	$42.3M+64.3%	$16.0M-54.0%	$70.0M+2301.5%	$27.4M+82.8%	$25.8M+191.2%	$34.8M-27.6%	$2.9M+173.8%
Investing Cash Flow	-$13.8M-485.3%	-$11.5M+20.2%	$8.6M-60.7%	-$2.7M-1053.5%	-$2.4M+91.5%	-$14.5M-223.5%	$21.8M+1676.1%	$288K+122.6%
Financing Cash Flow	-$20.9M-172.6%	-$26.7M-203.8%	-$19.6M+24.6%	-$27.3M-353.9%	-$7.7M+41.0%	-$8.8M-162.8%	-$26.0M-3.9%	-$6.0M-710.6%
Share Buybacks	$20.9M+172.7%	$24.0M+240.6%	$19.6M+1841.0%	$27.3M+2605.5%	$7.7M+155.8%	$7.0M	$1.0M-80.0%	$1.0M-74.9%

Not reported in any period shown, so not listed: Dividends Paid.

HCSG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCSG quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	13.0%-0.3pp	13.3%+0.4pp	12.8%+1.4pp	11.4%-2.6pp	14.0%-1.2pp	15.2%+2.8pp	12.4%+0.7pp	11.7%-1.8pp	13.5%-0.8pp	14.3%	N/A	N/A	N/A	N/A	N/A
Net Margin	3.2%+0.9pp	2.3%0.0pp	2.3%+0.3pp	2.0%-0.9pp	3.0%-2.6pp	5.6%+2.1pp	3.5%-0.7pp	4.2%-0.6pp	4.7%-0.2pp	5.0%+0.9pp	4.0%+2.4pp	1.7%-2.4pp	4.1%0.0pp	4.1%-0.2pp	4.3%
Return on Equity	11.6%+3.7pp	7.9%-0.5pp	8.4%+0.2pp	8.2%-2.7pp	10.9%-10.1pp	21.0%+6.9pp	14.0%-4.9pp	18.9%-3.1pp	22.1%-0.8pp	22.8%+3.3pp	19.6%+11.7pp	7.9%-8.6pp	16.5%-2.7pp	19.3%+1.7pp	17.5%
Return on Assets	7.4%+2.5pp	4.9%+0.1pp	4.9%+0.1pp	4.8%-1.5pp	6.2%-6.3pp	12.6%+3.6pp	8.9%-3.1pp	12.1%-1.0pp	13.1%-1.6pp	14.6%+2.6pp	12.1%+7.4pp	4.7%-6.4pp	11.1%-2.3pp	13.4%+0.2pp	13.2%
Current Ratio	3.38+0.5x	2.89+0.3x	2.64-0.1x	2.69-0.2x	2.86-0.7x	3.53+0.1x	3.47+0.4x	3.11+0.2x	2.86-1.2x	4.11+0.3x	3.80+1.0x	2.84-0.3x	3.12-0.8x	3.96-1.2x	5.11
Debt-to-Equity	0.560.0x	0.61-0.1x	0.730.0x	0.720.0x	0.75+0.1x	0.67+0.1x	0.570.0x	0.57-0.1x	0.69+0.1x	0.56-0.1x	0.62-0.1x	0.70+0.2x	0.490.0x	0.44+0.1x	0.33
Asset Turnover	2.31+0.2x	2.140.0x	2.11-0.2x	2.34+0.2x	2.11-0.1x	2.24-0.3x	2.55-0.3x	2.89+0.1x	2.75-0.2x	2.960.0x	2.99+0.2x	2.75+0.1x	2.70-0.5x	3.25+0.2x	3.07
FCF Margin	7.6%+6.1pp	1.4%-0.9pp	2.3%+3.1pp	-0.8%-2.7pp	1.9%-10.2pp	12.1%+7.2pp	4.9%+1.1pp	3.8%+3.6pp	0.1%-2.2pp	2.3%-1.8pp	4.1%0.0pp	4.0%+1.6pp	2.5%-2.8pp	5.3%+2.2pp	3.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	15.9%+15.2pp	16.4%+1.2pp	15.4%+2.1pp	20.8%+5.9pp	0.7%-9.1pp	15.2%-0.1pp	13.4%-4.2pp	14.8%+6.4pp
Net Margin	4.8%+11.9pp	5.6%+1.8pp	6.7%+4.0pp	9.3%+6.0pp	-7.1%-6.6pp	3.9%+0.2pp	2.7%-2.8pp	3.3%+4.5pp
Return on Equity	4.4%+11.2pp	5.1%+1.7pp	6.1%+3.7pp	8.7%+5.8pp	-6.8%-6.4pp	3.4%+0.1pp	2.4%-2.8pp	2.9%+4.0pp
Return on Assets	2.8%+6.8pp	3.2%+1.1pp	3.9%+2.5pp	5.3%+3.6pp	-4.0%-3.8pp	2.1%+0.2pp	1.5%-1.5pp	1.7%+2.4pp
Current Ratio	3.02+0.5x	3.11+0.2x	3.38+0.5x	2.970.0x	2.49-0.2x	2.89+0.1x	2.89+0.3x	2.93+0.1x
Debt-to-Equity	0.58-0.1x	0.590.0x	0.560.0x	0.620.0x	0.680.0x	0.60-0.1x	0.61-0.1x	0.65-0.1x
Asset Turnover	0.570.0x	0.570.0x	0.590.0x	0.580.0x	0.570.0x	0.540.0x	0.550.0x	0.530.0x
FCF Margin	4.3%-1.7pp	9.2%+3.4pp	3.4%-4.5pp	15.1%+14.4pp	6.0%+2.5pp	5.8%+12.4pp	7.9%-3.4pp	0.7%+0.4pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Healthcare Svcs Group Inc HCSG	FY2025	$1.8B	$59.1M	3.2%	$1.5B	39/100
PACS Group PACS	FY2025	$5.3B	$191.5M	3.6%	$6.9B	49/100
U S Physical Therapy USPH	FY2025	$781.0M	$39.6M	5.1%	$1.2B	56/100
Pediatrix Medical Group, Inc. MD	FY2025	$1.9B	$165.4M	8.6%	$2.2B	35/100
Astrana Health ASTH	FY2025	$3.2B	$24.0M	0.8%	$1.9B	49/100
Aveanna Healthcare Holdings, Inc. AVAH	FY2026	$2.4B	$225K	0.0%	$3.0B	36/100

Where Healthcare Svcs Group Inc Ranks

Frequently Asked Questions

What is Healthcare Svcs Group Inc's annual revenue?

Healthcare Svcs Group Inc (HCSG) reported $1.8B in total revenue for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Svcs Group Inc's revenue growing?

Healthcare Svcs Group Inc (HCSG) revenue grew by 7.1% year-over-year, from $1.7B to $1.8B in fiscal year 2025.

Is Healthcare Svcs Group Inc profitable?

Yes, Healthcare Svcs Group Inc (HCSG) reported a net income of $59.1M in fiscal year 2025, with a net profit margin of 3.2%.

What is Healthcare Svcs Group Inc's gross margin?

Healthcare Svcs Group Inc (HCSG) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthcare Svcs Group Inc's net profit margin?

Healthcare Svcs Group Inc (HCSG) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Healthcare Svcs Group Inc's return on equity (ROE)?

Healthcare Svcs Group Inc (HCSG) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Svcs Group Inc's free cash flow?

Healthcare Svcs Group Inc (HCSG) generated $139.2M in free cash flow during fiscal year 2025. This represents a 468.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Healthcare Svcs Group Inc's operating cash flow?

Healthcare Svcs Group Inc (HCSG) generated $145.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Svcs Group Inc's total assets?

Healthcare Svcs Group Inc (HCSG) had $794.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Healthcare Svcs Group Inc's capital expenditures?

Healthcare Svcs Group Inc (HCSG) invested $5.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Healthcare Svcs Group Inc buy back shares?

Yes, Healthcare Svcs Group Inc (HCSG) spent $61.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Svcs Group Inc have outstanding?

Healthcare Svcs Group Inc (HCSG) had 70M shares outstanding as of fiscal year 2025.

What is Healthcare Svcs Group Inc's current ratio?

Healthcare Svcs Group Inc (HCSG) had a current ratio of 3.38 as of fiscal year 2025, which is generally considered healthy.

What is Healthcare Svcs Group Inc's debt-to-equity ratio?

Healthcare Svcs Group Inc (HCSG) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Svcs Group Inc's return on assets (ROA)?

Healthcare Svcs Group Inc (HCSG) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Svcs Group Inc's P/E ratio?

Healthcare Svcs Group Inc (HCSG) trades at 12.3x earnings, its market capitalization divided by net income of $123.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Svcs Group Inc's price-to-sales ratio?

Healthcare Svcs Group Inc (HCSG) trades at 0.8x sales, its market capitalization divided by revenue of $1.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Svcs Group Inc's Piotroski F-Score?

Healthcare Svcs Group Inc (HCSG) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Svcs Group Inc's earnings high quality?

Healthcare Svcs Group Inc (HCSG) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Svcs Group Inc?

Healthcare Svcs Group Inc (HCSG) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.